Institution statistics

Past rankings:

Ranking timeline:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

^*Ratio includes only projects with > 2 partners

Summary:

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Partners:

Constancy:

Subjects: Diversity index:0.43

Categories:

Project overview:

Start date	Project	acronym	role	funding	partners
2020-05-01	Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA	INNODIA HARVEST	participant	5.999.055	40
2020-01-01	Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies	ImmUniverse	participant	15.500.000	26
2019-12-01	Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies	imSAVAR	participant	10.999.316	28
2019-11-01	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	participant	20.997.523	46
2019-11-01	EU Patient- cEntric clinicAl tRial pLatform	EU-PEARL	participant	12.004.953	36
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	31
2019-04-01	Biomarkers in Atopic Dermatitis and Psoriasis	BIOMAP	participant	10.500.000	32
2019-04-01	Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation	ConcePTION	participant	15.299.991	53
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	34
2019-03-01	Efficiently Networking European Neurodegeneration Research	NEURONET	participant	1.199.125	10
2019-03-01	Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts	IMMUcan	participant	17.830.000	28
2019-03-01	CARdiomyopathy in type 2 DIAbetes mellitus	CARDIATEAM	participant	6.700.000	21
2019-03-01	Neurotoxicity De-Risking in Preclinical Drug Discovery	NeuroDeRisk	participant	5.331.000	18
2019-02-01	Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease	TransBioLine	participant	13.999.998	27
2019-01-01	Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain	IM2PACT	participant	9.000.000	27
2019-01-01	Vaccines and Infectious Diseases in the Ageing PopuLation	VITAL	participant	5.499.882	24
2018-12-01	European Screening Centre; Unique Library for Attractive Biology	ESCulab	participant	18.249.993	20
2018-11-01	European Health Data and Evidence Network	EHDEN	participant	14.105.750	22
2018-07-01	Research empowerment on solute carriers (ReSOLUTE)	ReSOLUTE	participant	12.000.000	14
2018-06-01	The GetReal Initiative	GetReal Initiative	participant	1.750.000	17
2018-05-01	conect4children (COllaborative Network for European Clinical Trials For Children)	c4c	participant	67.000.000	48
2018-05-01	Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope	PIONEER	participant	6.000.000	35
2018-05-01	Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production	iConsensus	participant	4.700.000	19
2018-05-01	Hypoglycaemia - REdefining SOLutions for better liVEs	Hypo-RESOLVE	participant	13.450.057	23
2018-03-01	Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.	PARADIGM	participant	4.498.931	34
2017-11-01	Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections	COMBACTE-CDI	participant	2.312.305	14
2017-11-01	Liver Investigation: Testing Marker Utility in Steatohepatitis	LITMUS	participant	15.797.881	56
2017-10-01	European Quality In Preclinical Data	EQIPD	participant	4.495.523	30
2017-09-01	Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management	eTRANSAFE	participant	20.000.000	27
2017-09-01	Rheuma Tolerance for Cure	RTCure	participant	6.000.000	20
2017-07-01	Development of Robust and Innovative Vaccine Effectiveness	DRIVE	participant	8.999.813	15
2017-02-01	Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055	DO-IT	participant	3.549.833	36
2017-02-01	Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts	CUPIDO	participant	6.094.781	13
2017-01-01	Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030	TransQST	participant	8.000.000	23
2017-01-01	REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019	RESCEU	participant	14.498.125	18
2017-01-01	Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106	IB4SD-TRISTAN	participant	12.000.000	21
2017-01-01	Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine	MultipleMS	participant	14.721.453	22
2016-11-01	Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976	PHAGO	participant	8.838.000	20
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33
2016-09-01	Biomarker Enterprise to Attack DKD - Sofia ref.: 115974	BEAt-DKD	participant	15.085.937	31
2016-04-01	Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881	RHAPSODY	participant	8.130.000	27
2016-03-01	PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910	PERISCOPE	participant	21.000.000	24
2016-03-01	Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH).	MAST4HEALTH	participant	2.124.000	13
2016-03-01	Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924	VAC2VAC	participant	7.850.000	23
2016-01-01	Imaging the Force of Cancer	FORCE	participant	5.812.631	16
2016-01-01	ISOTOPIC LABELING FOR DRUG INNOVATION	ISOTOPICS	participant	3.948.844	13
2016-01-01	European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates	EHVA	participant	22.188.522	43
2015-11-01	Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797	INNODIA	participant	17.630.000	36
2015-09-01	Intensified by Design® for the intensification of processes involving solids handling	IbD	participant	8.484.489	23

overview shows latest 50 from 77 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here: